Soluble CD14, IL-18 and other immune activation mediators are produced in abundance in the liver in response to HCV and can act to perpetuate intrahepatic inflammation and progression of fibrosis and cirrhosis of the liver [38, 39]. This evidence concerns the gene CD14 and cirrhosis of liver.